150 likes | 159 Views
The seizure market is primarily driven by the increasing prevalence of traumatic brain injuries resulting from accidents, falls, and sports-related injuries, which can impair brain structure and function.
E N D
ABOUT IMARC International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Seizures Market 2023-2033 The newly published report by IMARC Group, titled ”Seizures Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the seizures market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players. What is seizures? Seizures refer to abrupt, irregular instances of electrical brain activity, leading to an assortment of physical and mental manifestations. These episodes stem from temporary perturbations in the routine functioning of brain cells, resulting in an unusual influx of electrical impulses. Standard symptoms include loss of consciousness, altered awareness, muscle spasms, sensory fluctuations, and emotional or behavioral alterations. The diagnosis of seizures requires a comprehensive assessment by healthcare professionals, typically comprising a thorough medical history, physical examination, and specific diagnostic tests.
Report Description and Highlights A neurological examination evaluates cognitive function, reflexes, and coordination. Electroencephalograms (EEG) and other diagnostic procedures record the brain’s electrical activity, facilitating the detection of irregular patterns indicative of seizures. Several imaging tests, including magnetic resonance imaging (MRI) and computed tomography (CT) scans, may be conducted to identify potential underlying structural abnormalities. Besides this, blood tests and genetic screening are utilized to ascertain possible metabolic or genetic origins. What are the key drivers and trends in the seizures market? The seizure market is primarily driven by the increasing prevalence of traumatic brain injuries resulting from accidents, falls, and sports-related injuries, which can impair brain structure and function. Moreover, the escalating incidence of associated risk factors, such as brain tumors, brain-affecting infections including meningitis, electrolyte imbalances, high fever, sleep deprivation, and genetic mutations, is aiding in market expansion. Besides this, the widespread adoption of antiepileptic drugs, including carbamazepine and lamotrigine, aimed at controlling seizure activity, minimizing the likelihood of seizure-associated complications, and enhancing patients’ quality of life, supports market growth.
Report Description and Highlights Additionally, the rising application of vagus nerve stimulation (VNS), a technique involving the implantation of a device to regulate abnormal brain activity and reduce seizure frequency, is aiding in market expansion. Furthermore, the advent of sophisticated imaging techniques, including functional magnetic resonance imaging (fMRI) and magnetoencephalography (MEG), are influencing market growth. Request a Sample Report : https://www.imarcgroup.com/seizures-market/requestsample
Report Description and Highlights What is included in the report segmentation? The report covers the following aspects: Report Period: • Base Year: 2022 • Historical Period: 2017-2022 • Market Forecast: 2023-2033 Countries Included: • United States • Germany • France
Report Description and Highlights • United Kingdom • Italy • Spain • Japan Analysis Covered Across Each Country • Historical, current, and future epidemiology scenario • Historical, current, and future performance of the Seizures market • Historical, current, and future performance of various therapeutic categories in the market • Sales of various drugs across the Seizures market • Reimbursement scenario in the market • In-market and pipeline drugs
Report Description and Highlights In-Market Drugs • Drug Overview • Mechanism of Action • Regulatory Status • Clinical Trial Results • Drug Uptake and Market Performance Late-Stage Pipeline Drugs • Drug Overview • Mechanism of Action • Regulatory Status • Clinical Trial Results • Regulatory Status View Report TOC, Figures and Tables: https://www.imarcgroup.com/seizures-market
Key Questions Answered in the Report • How has the Seizures Market performed so far and how will it perform in the coming years? • What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033? • What was the country-wise size of the Seizures Market across the seven major markets in 2022 and what will it look like in 2033? • What is the growth rate of the Seizures Marketacross the seven major markets and what will be the expected growth over the next ten years? • What are the key unmet needs in the market?
Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary
Table of Contents 4 Seizures - Introduction 4.1 Overview 4.2 Regulatory Process 4.3 Epidemiology (2017-2022) and Forecast (2023-2033) 4.4 Market Overview (2017-2022) and Forecast (2023-2033) 4.5 Competitive Intelligence 5 Seizures - Disease Overview 5.1 Introduction 5.2 Symptoms and Diagnosis 5.3 Pathophysiology 5.4 Causes and Risk Factors 5.5 Treatment Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/seizures-market/toc
Disclaimer © 2023 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.